Revenue of the cold & cough remedies market worldwide by country 2019

Published by A. Oloruntoba, Aug 26, 2020

This statistic depicts the revenue of the cold & cough remedies market in 2019, by country. In that year, the cold & cough remedies market revenue in the U.S. amounted to approximately 11,401.17 million U.S. dollars. For information on over 200 markets in 150 countries, please visit Consumer Market Outlook.

Revenue of the cold & cough remedies market worldwide by country in 2019 (in million U.S. dollars)

	Revenue in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Source

Show detailed source information?

Already a member?

Source

Show sources information

Show publisher information

More information

Supplementary notes

The cold and cough segment comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.